The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2020

Filed:

Jul. 27, 2016
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

David B. Frennesson, Naugatuck, CT (US);

Piyasena Hewawasam, Middletown, CT (US);

Omar D. Lopez, Walkersville, MD (US);

Van N. Nguyen, Auburn, MI (US);

Mark G. Saulnier, Higganum, CT (US);

Yong Tu, Cheshire, CT (US);

Alan Xiangdong Wang, Yardley, PA (US);

Gan Wang, Cheshire, CT (US);

Ningning Xu, Wallingford, CT (US);

Roshan Yadavrao Nimje, Bangalore, IN;

Hasibur Rahaman, Bangalore, IN;

Samayamunthula Venkata Satya Arun Kumar Gupta, Bangalore, IN;

Nicholas A. Meanwell, Yardley, PA (US);

Makonen Belema, North Haven, CT (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4178 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01); A61K 31/417 (2006.01); A61K 31/4184 (2006.01); A61K 31/7056 (2006.01); A61P 31/14 (2006.01); A61K 31/4439 (2006.01); A61K 31/497 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4178 (2013.01); A61K 31/417 (2013.01); A61K 31/4184 (2013.01); A61K 31/7056 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); A61P 31/14 (2018.01); A61K 31/4439 (2013.01); A61K 31/497 (2013.01); A61K 2300/00 (2013.01);
Abstract

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.


Find Patent Forward Citations

Loading…